INS and Hypoglycemia: Given the complex interplay between hemodialysis, insulin-based hyperkalemia treatment, and the risk of hypoglycemia, further research is needed to evaluate the outcomes of hyperkalemia management with insulin in patients with reduced kidney function, especially between hemodialysis-dependent and non-dependent patients.